United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Apr 16, 2026 · Filed Apr 17, 2026

On Apr 16, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$577.17 for US$5.77M under a trading plan, leaving 18,876 shares. Filed Apr 17, 2026 (Form 4).

Sold
10,000 shares
Price
US$577.17 average (US$573.91 to US$581.64)
Value
US$5.77M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 16, 2026Common StockOption exercise10,000US$135.4228,876Direct
Apr 16, 2026Common StockSale520US$573.9128,356Direct
Apr 16, 2026Common StockSale1,680US$574.7326,676Direct
Apr 16, 2026Common StockSale789US$575.6425,887Direct
Apr 16, 2026Common StockSale2,206US$576.9123,681Direct
Apr 16, 2026Common StockSale2,085US$577.8721,596Direct
Apr 16, 2026Common StockSale1,066US$578.8320,530Direct
Apr 16, 2026Common StockSale1,454US$579.6419,076Direct
Apr 16, 2026Common StockSale160US$581.0818,916Direct
Apr 16, 2026Common StockSale40US$581.6418,876Direct

Source

View original at SEC

Related